- Mesenchymal niche: the sensor and effector of leukemogenesis
-
Oh IH
- KMID: 2172766
- Blood Res.
- 2015 Jun;50(2):67-68.
- doi: 10.5045/br.2015.50.2.67
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Intraleukocytic hemozoin pigments in complicated Plasmodium falciparum cerebral malaria
-
Sultan S, Irfan SM
- KMID: 2172769
- Blood Res.
- 2015 Jun;50(2):72-72.
- doi: 10.5045/br.2015.50.2.72
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Pseudo gray platelet syndrome: the first case report in Korea
-
Yoo J, Kim Y, Han K
- KMID: 2172778
- Blood Res.
- 2015 Jun;50(2):117-118.
- doi: 10.5045/br.2015.50.2.117
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Gelatinous transformation of the bone marrow in hepatocellular carcinoma
-
Chang J, Park CJ
- KMID: 2172768
- Blood Res.
- 2015 Jun;50(2):71-71.
- doi: 10.5045/br.2015.50.2.71
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Reduced-intensity conditioning hematopoietic stem cell transplantation: looking forward to an international consensus
-
Chaudhry M, Ali N
- KMID: 2172767
- Blood Res.
- 2015 Jun;50(2):69-70.
- doi: 10.5045/br.2015.50.2.69
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Successful re-treatment with azacitidine in a patient with low blast count AML transformed from MDS after suspension of this agent
-
Niscola P, Tendas A, Scaramucci L, Giovannini M, Fratoni S, de Fabritiis P
- KMID: 2172776
- Blood Res.
- 2015 Jun;50(2):113-114.
- doi: 10.5045/br.2015.50.2.113
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- New approaches for cholestasis in hemoglobinopathies
-
Dhiman P, Saxena P, Bihari C, Rastogi A, Sarin SK
- KMID: 2172779
- Blood Res.
- 2015 Jun;50(2):118-121.
- doi: 10.5045/br.2015.50.2.118
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Prevalent factor XII deficiency in cancer patients with isolated aPTT prolongation
-
Shin DY, Lee HR, Kang HJ, Na II, Chang YH, Yang SH
- KMID: 2172777
- Blood Res.
- 2015 Jun;50(2):114-117.
- doi: 10.5045/br.2015.50.2.114
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Apoptosis: role in myeloid cell development
-
Sarvothaman S, Undi RB, Pasupuleti SR, Gutti U, Gutti RK
- KMID: 2172770
- Blood Res.
- 2015 Jun;50(2):73-79.
- doi: 10.5045/br.2015.50.2.73
Hematopoiesis is the process that generates blood cells in an organism from the pluripotent stem cells. Hematopoietic stem cells are characterized by their ability to undergo self-renewal and differentiation. The... -
- CITED
-
- Close
- SHARE
-
- Close
- Stability of eosin-5'-maleimide dye used in flow cytometric analysis for red cell membrane disorders
-
Mehra S, Tyagi N, Dorwal P, Pande A, Jain D, Sachdev R, Raina V
- KMID: 2172775
- Blood Res.
- 2015 Jun;50(2):109-112.
- doi: 10.5045/br.2015.50.2.109
BACKGROUND: The eosin-5'-maleimide (EMA) binding test using flow cytometry is a common method to measure reduced mean channel fluorescence (MCF) of EMA-labeled red blood cells (RBCs) from patients with red... -
- CITED
-
- Close
- SHARE
-
- Close
- Human coagulation factor VIII domain-specific recombinant polypeptide expression
-
Choi SJ, Jang KJ, Lim JA, Kim HS
- KMID: 2172774
- Blood Res.
- 2015 Jun;50(2):103-108.
- doi: 10.5045/br.2015.50.2.103
BACKGROUND: Hemophilia A is caused by heterogeneous mutations in F8. Coagulation factor VIII (FVIII), the product of F8, is composed of multiple domains designated A1-A2-B-A3-C1-C2. FVIII is known to interact... -
- CITED
-
- Close
- SHARE
-
- Close
- Down-regulation of the autophagy gene, ATG7, protects bone marrow-derived mesenchymal stem cells from stressful conditions
-
Molaei S, Roudkenar , Amiri F, Harati MD, Bahadori M, Jaleh F, Jalili MA, Mohammadi Roushandeh A
- KMID: 2172771
- Blood Res.
- 2015 Jun;50(2):80-86.
- doi: 10.5045/br.2015.50.2.80
BACKGROUND: Mesenchymal stem cells (MSCs) are valuable for cell-based therapy. However, their application is limited owing to their low survival rate when exposed to stressful conditions. Autophagy, the process by... -
- CITED
-
- Close
- SHARE
-
- Close
- Bortezomib inhibits the survival and proliferation of bone marrow stromal cells
-
Kim HY, Moon JY, Ryu H, Choi YS, Song IC, Lee HJ, Yun HJ, Kim S, Jo DY
- KMID: 2172772
- Blood Res.
- 2015 Jun;50(2):87-96.
- doi: 10.5045/br.2015.50.2.87
BACKGROUND: Bortezomib is widely used for the treatment of multiple myeloma. Bone marrow stromal cells (BMSCs) endow myeloma cells with survival and growth advantages. However, the influence of bortezomib on... -
- CITED
-
- Close
- SHARE
-
- Close
- Maximum standardized uptake value on positron emission tomography/computed tomography predicts clinical outcome in patients with relapsed or refractory diffuse large B-cell lymphoma
-
Jang HR, Song MK, Chung JS, Yang DH, Lee JO, Hong J, Cho SH, Kim SJ, Shin DH, Park YJ, Kang JS, Lee JE, Lee MW, Shin HJ
- KMID: 2172773
- Blood Res.
- 2015 Jun;50(2):97-102.
- doi: 10.5045/br.2015.50.2.97
BACKGROUND: Few clinical studies have clarified the prognostic factors that affect clinical outcomes for patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) after immunochemotherapy. METHODS: A total of 158... -
- CITED
-
- Close
- SHARE
-
- Close
